Zebrafish models of myeloid malignancies produced through tet2 and asxl1 genomic editing

被引：0

作者：

Gjini, Evisa ^{[1
]}

Mansour, Marc ^{[1
]}

Sander, Jeffry ^{[2
]}

He, Shuning ^{[1
]}

Ko, Myunggon ^{[3
]}

Zhou, Yi ^{[4
]}

Rodig, Scott ^{[5
]}

Joung, Keith ^{[6
]}

Zon, Leonard ^{[4
]}

Rao, Anjana ^{[3
]}

Look, Thomas ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] La Jolla Inst Allergy & Immunol, La Jolla, CA USA

[4] Childrens Hosp, Boston, MA 02115 USA

[5] Brigham & Womens Hosp, Boston, MA 02115 USA

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-5152

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5152

引用

页数：2

共 50 条

[21] TET2 mutations in myelodysplasia and myeloid malignancies
Mullighan, Charles G.
NATURE GENETICS, 2009, 41 (07) : 766 - 767
[22] TET2 mutations in myelodysplasia and myeloid malignancies
Charles G Mullighan
Nature Genetics, 2009, 41 : 766 - 767
[23] Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
Szpurka, Hadrian
Jankowska, Anna M.
Makishima, Hideki
Bodo, Juraj
Bejanyan, Nelli
Hsi, Eric D.
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P.
LEUKEMIA RESEARCH, 2010, 34 (08) : 969 - 973
[24] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
Van Ness, Michael
Szankasi, Philippe
Frizzell, Kimberly
Shen, Wei
Kelley, Todd W.
LABORATORY INVESTIGATION, 2016, 96 : 381A - 381A
[25] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
Van Ness, Michael
Szankasi, Philippe
Frizzell, Kimberly
Shen, Wei
Kelley, Todd W.
MODERN PATHOLOGY, 2016, 29 : 381A - 381A
[26] DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHEMIA VERA
Stuckey, Ruth
Segura Diaz, Adrian
Florido Ortega, Yanira
Sobas, Marta
Alvarez, Larran Alberto
Ferrer-Marin, Francisca
Perez, Encinas Manuel
Carreno, Gonzalo
Fox, Maria Laura
Tazon, Vega Barbara
Cuevas, Beatriz
Lopez, Rodriguez Juan Francisco
Farias-Sanchez, Nuria
Bilbao-Sieyro, Cristina
Gomez-Casares, Maria Teresa
HAEMATOLOGICA, 2021, 106 (10) : 15 - 16
[27] Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome
Feng, Yue
Liang, Haiping
Han, Meining
Luo, Xingchun
Zhu, Yu
Liu, Bei
HEMATOLOGY, 2023, 28 (01)
[28] Familial myeloid malignancies with germline TET2 mutation
Nicolas Duployez
Laure Goursaud
Laurène Fenwarth
Claire Bories
Alice Marceau-Renaut
Thomas Boyer
Elise Fournier
Olivier Nibourel
Catherine Roche-Lestienne
Guillemette Huet
David Beauvais
Céline Berthon
Nathalie Cambier
Bruno Quesnel
Claude Preudhomme
Leukemia, 2020, 34 : 1450 - 1453
[29] Familial myeloid malignancies with germline TET2 mutation
Duployez, Nicolas
Goursaud, Laure
Fenwarth, Laurene
Bories, Claire
Marceau-Renaut, Alice
Boyer, Thomas
Fournier, Elise
Nibourel, Olivier
Roche-Lestienne, Catherine
Huet, Guillemette
Beauvais, David
Berthon, Celine
Cambier, Nathalie
Quesnel, Bruno
Preudhomme, Claude
LEUKEMIA, 2020, 34 (05) : 1450 - 1453
[30] Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Abdel-Wahab, Omar
Mullally, Ann
Hedvat, Cyrus
Garcia-Manero, Guillermo
Patel, Jay
Wadleigh, Martha
Malinge, Sebastien
Yao, JinJuan
Kilpivaara, Outi
Bhat, Rukhmi
Huberman, Kety
Thomas, Sabrena
Dolgalev, Igor
Heguy, Adriana
Paietta, Elisabeth
Le Beau, Michelle M.
Beran, Miloslav
Tallman, Martin S.
Ebert, Benjamin L.
Kantarjian, Hagop M.
Stone, Richard M.
Gilliland, D. Gary
Crispino, John D.
Levine, Ross L.
BLOOD, 2009, 114 (01) : 144 - 147

← 1 2 3 4 5 →